CREON — Class II drug recall D-1611-2014
Terminated recall by AbbVie Inc, reported 2014-10-08, distributed nationwide. Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
| Recall number | D-1611-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc, North Chicago, IL, United States |
| Recall initiated | 2014-09-15 |
| Classified | 2014-09-26 |
| Reported by FDA | 2014-10-08 |
| Terminated | 2016-06-22 |
| Distributed | Nationwide (US) |
| Quantity | 18,021 bottles |
| NDC | 00032-0045, 00032-0045-30, 00032-0045-70, 00032-0046, 00032-0046-30, 00032-0046-70, 00032-0047, 00032-0047-30, 00032-0047-70, 00032-1203, 00032-1203-64, 00032-1203-70, 00032-1206, 00032-1206-01, 00032-1206-07, 00032-1206-56, 00032-1212, 00032-1212-01, 00032-1212-07, 00032-1212-13, 00032-1212-46, 00032-1224, 00032-1224-01, 00032-1224-07, 00032-1224-46 and 13 more |
| Lot numbers | 1020156 |
| Expiration dates | 2016-03-31 |
Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Reason for recall
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1611-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.